OR WAIT null SECS
© 2022 MJH Life Sciences and Optometry Times. All rights reserved.
© 2022 MJH Life Sciences™ and Optometry Times. All rights reserved.
A panel of ophthalmologists and optometrists conclude a discussion about dry eye disease by commenting on advances occurring in the field and future expectations for managing patients.
Unique clinical trials and novel products of interest currently under investigation for the treatment of dry eye disease.
Strategies that can help eye care specialists work with patients to establish and stick to treatment plans for dry eye disease.
Types of in-office procedures currently being used by ophthalmologists and optometrists to aid in the treatment of dry eye disease.
Eye care specialists describe when corticosteroid therapy should be considered to treat dry eye disease and describe best practices when treating pre-surgical patients.
Study: Neurolenses significantly impact reading speed
FDA approves biosimilar product ranibizumab-eqrn for retinal diseases
Aerie doses first patient in COMET-3 study for DED treatment
EyeCare4Kids names new executive director